ABSTRACT
INTRODUCTION
The major histocompatibility complex (MHC) class I genes (H-2K, D and L in mouse, HLA-A, B and C in humans) encode transmembrane glycoproteins which function in the process of immune recognition (1) . The class I antigens are heterodimers consisting of a polymorphic heavy chain non-covalently associated with an invariant light chain termed /3 2 -microglobulin (2) . Most nucleated somatic cells contain class I antigens at their surface (3) with the exception of brain and liver cells and certain cell populations of the placenta (4) .
Cytotoxic T lymphocytes (CTLs) recognise virally-infected or malignant cells by presentation of foreign peptides at the cell surface in association with the class I antigens (5) . A number of human cancers which have reduced levels of surface class I antigens have been identified and it has been proposed that such reduced levels of class I expression allow tumour cells to escape immune surveillance (6, 7) . Therefore it is possible that a reduction in the level of surface class I antigens may be an important process in the multi-step pathway to oncogenesis.
Cells transformed by human adenoviruses are a potentially useful system for studying the mechanism of down-regulation of class I gene expression. The human adenoviruses (Ads) are a group of double-stranded DNA viruses which can be classified according to their oncogenicity in newborn rodents. Subgroup A viruses (e.g. Adl2) are highly oncogenic, whereas subgroup C viruses (e.g. Ad2, Ad5) are non-oncogenic. All adenoviruses can transform primary cultures of rodent cells (8) and the genetic information necessary for transformation has been mapped to the left 11 % of the adenovirus genome, termed early region 1, or El. Two transforming genes are present within this region, El A and E1B (reviewed in 9). Expression of the products of both the El A and E1B genes is necessary for full and stable transformation *To whom correspondence should be addressed (10) but it is the serotypic origin of the El A gene which determines the oncogenicity of the transformed cell (11) . Thus highly oncogenic Adl2-transformed cells exhibit reduced levels of surface class I antigens, whereas non-oncogenic Ad2-and Ad5-transformed cells have unaltered or elevated levels of surface class I antigens (12 -16) . This down-regulation of class I expression in Adl2-transformed cells has been shown to occur mainly at the level of initiation of class I mRNA transcription (17) (18) (19) (20) .
The mouse H-2K b class I promoter has been extensively analysed and a major class I regulatory element identified at position -159 to -201bp upstream of the transcriptional initiation site (21, 22) . Several transcription factors have been identified which bind to domains of this element, including NFxB (23) , KBFI (24) , H2TFI (22) , MBP-1 (25) and H2RIEBP (26) as well as factors which have not yet been characterised (27, 28) . Therefore this element has been shown to be a major site of control of class I transcription. It has been identified as both a site of down-regulation (29) and as a site of positive control (30) of class I expression in Adl2-transformed cells. Altered levels of NF-xB in the nucleus of Ad-transformed cells (which are elevated in Ad5-, compared to Adl2-transformed cells) have also been proposed as the explanation for differences in expression of MHC class I genes (31, 32) . Another element, located further upstream at -1521 to -1837 bp in the mouse H-2K bml promoter, has been reported to be the target for Adl2 ElA-mediated downregulation of class I transcription (30) . In view of these contradictory reports, we have investigated the 5' flanking region of the H-2K b class I promoter for regulatory elements targeted by Ad 12 El A by the use of CAT reporter gene fusion constructs and reporter gene assays. We have identified a major site of down-regulation within the H-2K b promoter which is targeted by Adl2 E1A. The targeted region is located at -1.07 to -1.44kb upstream of the transcriptional start site. This region has been dissected and analysed for DNA: protein interactions in gel retardation assays and it has been shown to bind nuclear factors from Adl2-transformed cells, but not from Ad2-or Ad5-transformed cells.
MATERIALS AND METHODS Plasmids
The pBLCAT3 and pBLCAT2 reporter gene vectors used in this study have been previously described (33) . They contain the chloramphenicol acetyl transferase (CAT) gene, under the control of a herpes simplex virus thymidine kinase (tk) basal promoter (in pBLCAT2) or without a promoter (in pBLCAT3). Standard cloning techniques were used to sub-clone DNA fragments from the murine H-2K b gene into either CAT vector (34) . H2KCAT was constructed by ligating a 2kb Nrul/Hindni fragment of the 5' flanking region of the H-2K b gene into the BglR site of pBLCAT3, following filling-in of the ends of the fragment and vector with the Klenow fragment of DNA polymerase I. The H2KCAT Del I deletion plasmid was made by deleting the region between -1.49 to -1.18kb of the H-2K b promoter between two Bell restriction sites. All other H-2K b DNA fragments were cloned into pBLCAT2 to test the DNA fragment as a putative enhancer or repressor element on the heterologous tk promoter. The construct p(-0.1/-2.0)tkCAT was made by blunt end cloning a 1.9kb HindWHindi fragment from H2KCAT into the BamHl site of pBLCAT2. This construct removes the TATA box and CAAT box of the H-2K b promoter. The p(-0.4/-2.0)tkCAT construct was made by cloning into the Xbal site of pBLCAT2 using Xbal linkers. The construct p(-0.1/-1. l)tkCAT was made by deleting a 900bp StuUHindUl fragment from -1.1 to -2.0kb in the p(-0.1/-2.0)tkCAT construct. The p(-l.l/-2.0)tkCAT construct was made by cloning the 900bp Stul/Hindm fragment into the Xbal site of pBLCAT2 using Xbal linkers. The p(-1.59/-2.0)tkCAT construct was made by cloning an AspVHindUl fragment into the Xbal site of pBLCAT2, again using Xbal linkers.
All other constructs were made by generation of specific PCR products, synthesised using primers containing BarriHl restriction sites. Following digestion with BamHl, PCR products were cloned directly into the BamHl site of pBLCAT2. The constructs, p(-1.07/-1.18)tkCAT and p(-1.18/-1.44)tkCAT, were prepared by Bed digestion of the -1.07/ -1.44kb PCR product and cloning the subsequent BcWBamHl fragments into the BamHl site of pBLCAT2. The plasmid tk/3Gal, used as an internal reference for transfection, has been previously described (35) . pElASV is the Xbal/HpaU. fragment of Ad2 El A cloned into pBR322 and pEl A~ is a derivative of pElASV which lacks the E1A coding region (36) . pAsc 4.7 is theAccl-H fragment of Adl2 (El A plus the 5' end of the EIB gene) cloned between the/lccl and £coRI sites of pBR322 (37) . pIBI30, a pUC18-based cloning vector (International Biotechnologies Inc., New Haven, USA) was used as a control plasmid in cotransfections.
PCR Polymerase chain reaction (PCR) was carried out in a Perkin
Elmer Cetus thermocycler using a basic profile of denaturation at 95°C for 1 min, annealing of primers at 55°C for 1 min and extension of primers at 72°C for 2 mins for 30 cycles. H2KCAT (lOng) template was used in 1 x Vent reaction buffer (supplied by the manufacturer) with dNTPs and primers added to final concentrations of 0.2mM and 0.2-1.0mM respectively. Amplification was carried out using Vent DNA polymerase (New England Biolabs).
DNA sequencing Cloned PCR products were sequenced to confirm orientation and sequence fidelity. The T7 polymerase sequencing kit (Pharmacia) was used following manufacturers' protocols.
Cell lines and tissue culture Primary baby rat kidney (BRK) cells were prepared from seven day old pathogen-free Wistar rats as previously described (38) . RFC1 is an Adl2-transformed Hooded Lister rat kidney cell line (39) . Adl2 100.1 is an Adl2-transformed cell line (40) . 5A12 is a BRK cell line transformed with a recombinant Ad5 virus expressing Adl2 E1A and Ad5 EIB (11) . 5B12 is a BRK cell line transformed with a recombinant Ad5 virus expressing Ad5 E1A and Adl2 EIB (11) . A5#2 and Ad5Xho are Ad5-transformed BRK cell lines (kindly supplied by K.A.Raska). Ad5 ME1 and Ad 12 ME1 are mouse embryo cell lines transformed by Ad5 and Ad 12 viruses respectively (kindly supplied by A.M.Lewis). 3YI cells are established Fischer rat embryo fibroblasts (41) . Other cell lines used in this study have been described previously (42) .
Cells were grown in DMEM medium, supplemented with 10% (v/v) foetal calf serum (FCS) for primary cells and donor calf serum (DCS) for cell lines, in a humidified atmosphere containing 5% CO 2 at 37 °C.
Transfections and reporter gene assays
Cells were transfected by the calcium phosphate:DNA coprecipitation method (43) using a total of 20/tg DNA comprising 2^g tk/3Gal along with 18/tg of test plasmid. In cotransfections with ElA-expressing plasmids 9mg of reporter gene plasmid was mixed with 9/ig El A expression plasmid (or pIBI30 control plasmid vector). Forty hours post-transfection cells were harvested and /3 galactosidase and CAT activities were assayed using standard methods (44) . CAT assays were quantified by scintillation counting of spots excised from TLC plates (44) or molecular imaging analysis using a Fuji BAS 1000 phosphorimager. The volume of cell extract used was standardised by tkjSGal activity to account for variations in transfection efficiencies between plates of cells.
Transfection experiments were repeated at least three times each, with more than one batch of each plasmid. The variance of CAT activities recorded between replicate assays with one plasmid was not greater than 10%.
Preparation of nuclear extracts and gel retardation
Nuclear extracts were prepared by the small-scale method described previously (45) . The protein concentration of extracts was determined by a dye-binding protein assay (BioRad Laboratories).
DNA probes were prepared by digesting PCR products with BamHI to generate 5' overhanging ends. The Klenow fragment of DNA polymerase I was used to fill in the termini with [a- 32 P] dGTP and a mixture of unlabelled dCTP, dATP and dTTP (34) . DNA binding reactions were prepared and analysed by polyacrylamide gel electrophoresis as previously described (27) . Where competition assays were performed, a 100-fold excess of unlabelled DNA fragment was added to the reaction before addition of the labelled DNA probe. The sequences of the AP-1 and PD1 double-stranded competitor oligonucleotides were (upper, coding strand):
Computer analysis of DNA sequences All computer analysis was performed on a Macintosh Quadra 650 computer using programs from the MacVector Sequence Analysis software (International Biotechnologies, USA). The Pustell matrices program was used to perform sequence alignments. Sequence homology searches were performed against the Entrez database discs (National Center for Biotechnology Information, NIH, Bethesda).
RESULTS

Down-regulation of a murine MHC class I promoter in adenovirus 12-transformed cells
We and others have previously shown that expression of endogenous MHC class I genes is down-regulated in Ad 12-transformed cell lines and is unaffected or up-regulated in Ad2-or Ad5-transformed cell lines and that this down-regulation is mediated by Ad 12 El A protein(s) at the level of initiation of transcription (17) (18) (19) (20) . To locate elements within the 5' flanking region of the mouse H-2K b class I gene which are targets for down-regulation by Ad 12 El A we have used transient expression and gel retardation assays.
The 2kb 5' flanking region of the H-2K
b gene was cloned into the pBLCAT3 reporter gene vector generating the H2KCAT plasmid (Fig.l) . In this construct the H-2K b promoter was fused directly to the CAT reporter gene. Figure 1 shows the position of the class I regulatory element (CRE) and interferon consensus sequence (ICS), both of which have been previously described (23, 21) . All subsequent clones were constructed in pBLCAT2 (which contained the HSV thymidine kinase basal promoter) and are shown schematically in Fig. 1 .
The H2KCAT construct was used in transient expression assays in a series of Ad 12-and Ad5-transformed rat and mouse cell lines (Fig. 2) . In all Adl2-transformed cell lines CAT expression driven by the H-2K b promoter region was substantially down- regulated compared to the levels of CAT activity observed in Ad5-transformed cell lines. Next, the H2KCAT construct was used in co-transfection assays along with plasmids designed to express either the Adl2 or Ad2 E1A proteins, in normal primary BRK cells or established 3YI fibroblasts (Table 1 ). In both cell types, Ad2 El A expression increased CAT activity by 2 -3 fold when compared to co-transfection with a control plasmid cloning vector (pIBDO) whereas Ad 12 El A expression down-regulated reporter gene expression by a similar factor. Substitution of an Table 1 CAT plasmids (described in Fig. 1 ) were co-transfected with Ad2 El A or Adi 2 E1A expression plasmids or a negative control plasmid, pD3I30 (-E1A) into primary BRK cells, as described in Materials and Methods. Transfection efficiency was controlled by the inclusion of the tk/3gal plasmid. CAT activity of the cell extracts was measured as described in Materials and Methods and is presented as a percentage conversion of [ l4 C]chloramphenicol to its acetylated derivatives. Cotransfections were performed at least three times with more than one batch of plasmid and the average of the CAT conversions are shown here. Variance between individual transfections with one plasmid was not greater than 10% Ad2 E1A~ plasmid, where the El A coding region was removed, for pIBDO gave identical results (not shown). These results show that specific down-regulation of the H-2K b promoter is Ad 12 ElA-mediated and is not a secondary effect of Ad 12 transformation.
Localisation of the site of transcriptional down-regulation mediated by Adl2 E1A
The first step in localising the site of down-regulation was to test whether the H-2K b 5' flanking region from which basal elements had been deleted could down-regulate CAT expression driven from a heterologous basal promoter in Ad 12 E1A-expressing cells. The thymidine kinase basal promoter present in pBLCAT2 was used for this purpose.
The 1.9kb of 5' flanking sequence of the H-2K b gene which removed the TATA and CAAT boxes was cloned into pBLCAT2 ( Fig. 1 ) and used in transient expression assays in Adl2-transformed cells (Table 2) as well as cotransfection assays in BRK cells ( Table 1 ). The vector pBLCAT2 was used in control transfections and showed no substantial differences in CAT activity generated in the presence of Ad2 or Ad 12 El A ( Table  1) . Cotransfection of p(-0.1/-2.0)tkCAT with an Adl2 E1A expression plasmid resulted in at least a 3-fold repression of CAT activity whereas CAT expression was stimulated by expression of Ad 2 El A (Table 1) . Furthermore, in transient expression assays in Adl2-transformed RFC1 cells this promoter fragment directed an approximately 14-fold repression of CAT activity ( Table 2) .
Next it was important to determine whether the major class I regulatory element, the CRE, was involved in Ad 12 ElAmediated repression of class I transcription. To investigate this possibility, a plasmid clone, p(-0.4/-2.0)tkCAT, was constructed which eliminated the CRE (Fig. 1) . In cotransfection studies this clone directed an elevated CAT activity with Ad2 El A and down-regulated CAT activity when cotransfected with Ad 12 El A (Table 1 regulated by 14-fold when compared to CAT activity generated by transfection of the parental pBLCAT2 plasmid (Table 2) . These results therefore indicated that a major site of negative regulation by Ad 12 El A was located within a more distal site, -0.4 to -2.0kb upstream of the site of transcriptional initiation site than the CRE.
To delineate the Adl2 ElA-responsive sequence further, two plasmids were constructed which divided the H-2K b 5' flanking region into two similar size fragments: p(-0.1/-1. l)tkCAT and p(-l.l/-2.0)tkCAT. The first of these constructs, p(-0.1/-1. l)tkCAT, when analysed in transient cotransfection assays with Adl2 E1A in primary cells, directed slightly elevated levels of CAT expression, 1.8-fold greater than the basal level found with cotransfection of pIBDO with p(-0.1/-1. l)tkCAT (Table 1 ). In transfection studies in Adl2-transformed cells this construct directed a similar level of CAT activity to the basal level observed with transfection of pBLCAT2 ( Table 2) . Cotransfection of the p(-1. l/-2.0)tkCAT plasmid with Ad 12 El A gave 3-fold down-regulation compared to the basal level of CAT activity (Table 1 ). In transfection into Adl2-transformed cells, CAT activity directed by p(-1. l/-2.0)tkCAT was again down-regulated, approximately 24-fold compared to the pBLCAT2 control (Table 2) . These results are consistent with the notion that the site of Ad 12 ElA-mediated down-regulation is positioned within the -1.1 to -2.0kb sequence. Therefore the -1.1 to -2.0kb sequence was dissected into two smaller fragments, generating the p(-1.59/-2.0)tkCAT and p(-1.07/-1.61)tkCAT clones. Expression of the p(-1.59/-2.0)tkCAT construct was not significantly downregulated by Ad 12 El A, with CAT activity remaining Plasmids were transfected into Adl2-or Ad5-transformed cells and CAT activity assayed as described in Table 1. approximately the same as the basal level in both cotransfection assays in primary BRK cells and in transfection assays for Adl2-transformed cells (Tables 1 and 2 ). However, in both cotransfection and transfection assays p(-1.07/-1.61)tkCAT was down-regulated by Adl2 E1A by approximately 3-fold, compared to controls. Therefore, the major region of downregulation was localised to the region -1.07 to -1.61kb relative to the site of transcriptional initiation. To delineate the downregulatory region more precisely, a smaller clone was made using an upstream PCR primer approximately 0.17kb from the original -1.61kb site, but maintaining the downstream primer at its -1.07kb position. In transfection studies in RFC1 cells, repression with the p(-1.07/-1.44)tkCAT construct was even greater than for p(-1.07/-1.61)tkCAT and was approximately 12-fold less than CAT activity driven by pBLCAT2. The p(-1.07/-1.44)tkCAT construct was down-regulated by Adl2 El A to a similar degree as the p(-1.07/-1.61)tkCAT clone in cotransfection studies (Table 1) and showed an even greater degree of down-regulation than p(-1.07/-1.61)tkCAT in Adl2-transformed cells (Table 2) .
To continue localisation of target sequences, the -1.07 to -1.44kb PCR fragment was digested into two smaller fragments, -1.07/-1.18kb and -1.18/-1.44kb, by BcR. Both fragments were cloned into pBLCAT2 to generate the constructs p(-1.07/-1.18)tkCAT and p(-1.18/-1.44)tkCAT. Overlapping PCR products which spanned the -1.18 to -1.44kb sequence were prepared and cloned in pBLCAT2. Each fragment was 110-120bp in length and overlapped adjacent fragments by 20-30bp (shown in Fig. 4D ). CAT activity directed by the p(-1.07/-1.18)tkCAT construct was slightly elevated above basal levels suggesting that this sequence was not involved in functional Ad 12 ElA-mediated repression of the H-2K b promoter. In contrast p(-1.18/-1.44)tkCAT directed a substantial reduction in CAT activity, approximately 18-fold less than the basal level driven by pBLCAT2, indicating that a major target of Ad 12 ElA-mediated repression was located within this 260bp sequence. The remaining three PCR-generated constructs all showed differing levels of reduced CAT activity, however, no single construct gave a reduction as great as that for p(-1.18/-1.44)tkCAT, suggesting the requirement of a significant portion of the 260bp sequence to achieve maximal repression of H-2K b transcription.
A complementary approach was adopted both to confirm the location of the region of down-regulation and to create a system more representative of the intact H-2K b promoter. This involved constructing a deletion plasmid (H2KCAT Del 1) where a 310bp fragment from -1490 to -1180bp between two Bell restriction sites was removed. This deletion removed the entire sequence, -1.18/-1.44kb, identified as the target for Adl2 ElA-mediated repression, but retained the CRE and basal elements of the H-2K b promoter (Fig. 1 ). This deletion construct was cotransfected into primary BRK and established 3YI cells and compared with cotransfection of the parent H2KCAT construct (Table 1) . Interestingly, deletion of the 310 bp sequence appeared to increase the basal CAT expression directed by the H2KCAT Del 1 construct cotransfected with pIBI30 in normal BRK cells and especially in 3YI cells. This might suggest that the -1.18 to -1.49 kb sequence negatively regulates class I transcription in normal cells. Cotransfection with Ad 12 El A gave greatly elevated CAT activities with the deletion construct compared to wild-type H2KCAT in both BRK and 3YI cells, indicating that a region of repression had indeed been removed. This experiment was repeated in Adl2-and Ad5-transformed cell lines using increasing amounts of each plasmid, i.e. 5/tg, 10/ig and 20/ig. (The total plasmid DNA concentration was maintained at 20^g by the addition of pIBI30 plasmid.) At 5/tg of plasmid there was little difference in CAT activity generated using either the wild-type H2KCAT or mutant H2KCAT Del 1 constructs in Adl2-transformed cells (Table 2) . However, at both 10/ig and 2(tyig of plasmid, the mutated 5' flanking sequence directed a level of CAT expression 3-fold higher than that generated by the wild-type H2KCAT promoter. In Ad5-transformed cells there was little significant difference in CAT activity obtained with the mutant and wild-type constructs in the 5/tg and the 10/ig transfection experiments, although at 2O/tg plasmid, H2KCAT was expressed at slightly higher levels. All transfections shown here were performed with RFC1 cells in order to maintain consistency. However, transfections were also performed in Adl2 ElA-expressing 5A12 cells with identical patterns of CAT activity to those obtained with RFC1 (results not shown).
Computer analysis of the -1.18 to -1.44kb sequence involved in Adl2 ElA-mediated transcriptional downregulation Computer analysis of the -1.18 to -1.44kb sequence was performed to identify potential common sequences between this region and other reported transcriptional regulatory sequences. Two matches of approximately 50% were identified for the sequences -1226/-1257bp and -1206/-1237bp with a sequence previously identified as a silencer element involved in transcriptional regulation of the pig MHC class I gene, PD1 (Fig.  3A) . The PD1 sequence shows moderate sequence homology to the binding site for the yeast a2 repressor (46) , however no homology was found between the sites identified in the H-2K b sequence and the yeast a2 site (data not shown).
The -1.18/ -1.44kb sequence was also analysed for common transcription factor consensus sequences, to investigate the possibility that a ubiquitous transcription factor may be induced, complexed or modified by Ad 12 ElA to repress MHC class I transcription. Two potential AP-1 recognition sites were identified in the -1.23/-1.35kb DNA fragment, at positions -1246 to -1253bp and -1300 to -1307bp. Both sequences showed a 6/7 base match to the AP-1 consensus sequence (Fig. 3B) . Both putative AP-1 recognition sites had a G residue substituted for a C residue in the inverted repeat region of the AP-1 consensus, rendering them non-canonical.
Sequence alignment and Diagon plot analysis of the -1.18 to -1.44kb sequence identified no significant sequence repetitions within this region of the H-2K b 5' flanking region (results not shown). To investigate DNA:protein complex formation with DNA sequences from the -1.18 to -1.44kb region which is targeted by Adl2 ElA for transcriptional down-regulation, three cloned overlapping PCR fragments were end-labelled and used in gel retardation assays with nuclear extracts derived from several Ad 12-and Ad5-transformed rat cells as well as untransformed primary BRK cells (Fig. 4) . The -1.32/-1.44kb fragment generated three DNA:protein complexes with nuclear extract prepared from Adl2-transformed RFC 1 cells. One complex, termed C2, was not significantly reduced in the presence of unlabelled competitor and was therefore considered to be nonspecific. DNA:protein complexes which comigrated with the C2 and C3 complexes were also generated with extract prepared from Ad5-transformed cells and primary BRK cells. The third complex, Cl, was detected in Adl2-transformed cells and at much lower levels in primary BRK cells (Fig. 4A ). This complex was barely detectable using nuclear extracts derived from Ad5-transformed cells. In addition a DNA:protein complex which migrated at a position between Cl and C2 was formed in Ad5-transformed and normal BRK cells, but not in Adl2-transformed cells. Gel retardation analysis with the -1.23/-1.35kb fragment also generated a closely-spaced triplet with nuclear extract prepared from Adl2-transformed RFC1 cells, all of which were competed out with unlabelled DNA fragment (Fig. 4B) . Binding assays using primary BRK nuclear extracts resulted in the formation of three similar complexes which comigrated with those formed using nuclear extracts from Adl2-transformed cells. However, the complexes found in primary BRK cells were present at much lower levels than those in Adl2-transformed cells. Trace amounts of the D3 complex, which comigrated with a similar complex formed from Adl2-transformed cells, were also formed with nuclear extract prepared from Ad5-transformed Ad5 Xho cells. However the Dl and D2 complexes were found only in Adl2-transformed cells and, at much lower levels, in primary BRK cells. The remaining fragment, -1.15/-1.26kb generated a single specific DNA:protein complex (termed El) with nuclear extract prepared from an Adl2-transformed cell line, 5A12 (Fig. 4C ). This fragment did not form complexes with proteins present in nuclear extracts prepared from either Ad5-transformed cells or untransformed primary BRK cells. To assess the relationship of the DNA: protein complexes formed using Adl2-transformed cell nuclear extract and the cloned PCR products to the AP-1 and PD1 factors revealed by the computer analysis (Fig. 3) , competition experiments were performed using AP-1 and PD1 binding sites in gel retardation (Fig. 5) . The AP-1 binding site failed to compete for binding of Adl2-transformed cell nuclear factors to the three DNA fragments, (Fig. 5A-C) . A similar result was obtained with the PD1 site as competitor except that some competition was noted for formation of the El complex, using the -1.26 to -1.15 kb fragment (Fig. 5C) . PCR was also used to generate smaller DNA fragments of 30 bp which overlapped the central PCR product shown in Fig. 4D (i.e. -1.23 to -1.26 kb and -1.32 to -1.35  kb) . The 30 bp fragments were analysed by gel retardation using Adl2-transformed cell nuclear extract ( Fig. 5D and E) . Again, although specific DNA:protein complexes were formed using both fragments, their formation was not abolished by either unlabelled AP-1 or PD1 binding sites. This result also suggests that the site where competition was noted by the PD1 binding site for El complex formation must be located between -1.15 and -1.23 kb.
Binding of nuclear proteins from
DISCUSSION
One mechanism whereby the highly oncogenic human adenovirus-transformed cells avoid cytotoxic T cell recognition is by down-regulation of MHC class I transcription. The results presented in this study have identified a sequence in the H-2K b 5' flanking region which is targeted by Ad 12 El A resulting in transcriptional down-regulation. A 260bp sequence from -1.18 to -1.44kb (relative to the cap site) was identified as the minimal target for Ad 12 ElA-mediated down-regulation of both the homologous basal promoter of the H-2K b gene and a heterologous HSV thymidine kinase basal promoter. Further dissection of this region reduced the observed down-regulatory effect, suggesting that more than one element is targeted over this region and that these elements may function cooperatively to achieve maximal down-regulation. Deletion of the entire -1.18 to -1.44kb region from the wild-type H-2K b promoter abolished down-regulation by Adl2 E1A, providing strong evidence that this region is a major target for Adl2 ElA-mediated down-regulation.
Considerable attention has been directed to the possibility that the class I regulatory element (CRE) could represent a target for Ad 12 ElA-mediated down-regulation of class I expression. Region II of the CRE was reported to be a site of Ad 12 El A- mediated transcriptional repression, due to increased binding of a member of the nuclear hormone receptor superfamily (29) . This binding was also reported to be dependent upon the presence of the positive enhancer element, CRE region I, which binds NFxB, H2TFI and other factors (28) . Other work has concluded that repression of class I transcription in Adl2-transformed cells is a result of diminished enhancer activity of the CRE region I due to reduced levels of NF-xB in Adl2-transformed cells compared to Ad5-transformed cells (31) . It was reported that differences in MHC class I expression between Ad-transformed cells were attributable to higher levels of nuclear NF-xB as a consequence of the constitutive expression of /3-interferon in Ad5-but not Adl2-transformed cells (32) . These studies have utilised transient expression directed by either single or multiple copies of transcription factor binding sites cloned into heterologous basal promoter-CAT expression vectors (28) (29) (30) (31) or gel retardation analysis (32) . In contrast in this study, a systematic mutational analysis of the 2 kb 5'-flanking region of the H-2K b gene was coupled with DNA:protein complex analysis to define an Adl2 ElA-responsive element.
This analysis of class I promoter function revealed an active, ElA-mediated down-regulation of class I transcription, rather than a lack of transactivation in Adl2-transformed cells due to a reduction in NF-xB levels, as previously proposed (31, 32) . Furthermore, when the -1.18 to -1.44kb element was deleted from the H2KCAT construct, this resulted in transactivation of CAT gene expression in the presence of Ad 12 El A. This is in agreement with previous results which found the CRE to be a target for Adl2 ElA-mediated positive regulation of MHC class I transcription, although the presence of a more distal negative element resulted in overall down-regulation of MHC class I gene expression in Adl2-transformed cells (30) .
A previous study (30) described a 316 bp Adl2 ElA-responsive negative regulatory element located at -1521 to -1837bp in the mouse H-2K bml promoter (which differs from the H-2K b promoter by a single base pair deletion at position -456). However, in this study no functional evidence was obtained for this region of the mouse H-2K b promoter acting as a negative regulatory element in Ad 12 ElA-expressing cells. Transient expression analysis of H2KCAT Del 1, which contained the entire 316bp sequence but had the -1.18 to -1.44kb sequence deleted resulted in abrogation of Ad 12 ElA-mediated down-regulation. The reasons for the difference between this and the previous study (30) remain to be established, but could include the cell-type origin of the Ad-transformed cells, or the plasmid constructs used.
Analysis of the region of Ad 12 ElA-mediated down-regulation within the H-2K b promoter/enhancer for specific protein binding sites revealed several DNA:protein complexes which were formed using nuclear extracts from Ad 12-but not Ad5-transformed cells. In addition, certain DNA:protein complexes were formed at lower levels with nuclear extract prepared from primary, non-transformed BRK cells which comigrated with the complexes generated using nuclear extracts from Ad 12-transformed cells. Analysis of each PCR-generated DNA fragment in transient expression assays revealed a downregulation of CAT activity directed by each fragment in the presence of Adl2, but not Ad2 E1A. However, no single DNA fragment directed a reduction in CAT expression as significant as that by p(-1.18/-1.44)tkCAT, the construct containing the entire 26Obp repressory sequence. This suggests that multiple sites within the 26Obp sequence are required for transcriptional down-regulation of the H-2K b gene and that these sequences may function in a cooperative manner to achieve maximal repression. The mechanism by which Adl2 E1A directs downregulation of MHC class I transcription probably involves cellular factors as the El A proteins have no intrinsic DNA-binding properties (47) . In addition a number of interactions have been identified between El A and other cellular transcription factors such as ATF (48, 49) and AP-1 (50) . Therefore it is possible that El A mediates its effect by a direct interaction with cellular transcription factors. Alternatively, El A may function by inducing or activating a factor(s) resulting in DNA binding, for example El A may increase the specific activity of a cellular factor for its recognition site. In keeping with the latter model, low levels of DNA:protein complex were identified using primary BRK extract in binding assays with the fragments -1.23/-1.35kb (corresponding to Dl) and -1.32/-1.44kb (corresponding to Cl). These BRK cell complexes comigrated with complexes present at a much higher level generated with nuclear extract from Adl2-transformed cells and therefore may represent activation of cellular transrepressing factors by Ad 12 El A.
Computer analysis of the -1.18 to -1.44kb sequence for common transcription factor recognition sites identified two 6/7bp matches for AP-1 binding and two matches to a repressor binding site in the PD1 promoter. The repressor binding site sequence is required for transcriptional regulation of the pig PD1 MHC class I gene and consists of two protein binding sites, separated by a 10 bp spacer region (51) . Sequence homology between the PD1 repressor and H-2K b sequences is greatest in the spacer region. The observation that PD1 competed for binding of a nuclear factor in Ad 12-transformed cells to the -1.26 to -1.15 kb (the El complex in Fig. 5C ) might be explained by competition of the spacer region rather than the protein binding regions of the PD1 fragment. We are currently analysing further the physical and functional relationships of the El factor to the PD1 repressor. Ad5 El A has been reported to block the transactivation domain of DNA-bound AP-1, resulting in down-modulation of the transactivating function of AP-1 in human collagenase gene transcription (50) . However, the AP-1 binding site failed to compete in gel retardation analysis using Ad 12-transformed cell nuclear extract and DNA probes derived from the -1.18 to -1.44 region. This suggests that many of the DNA:protein complexes found result from novel factors.
Although adenovirus El A proteins exhibit transrepressional effects on the transcription of a number of cellular genes (52), repression of the MHC class I gene is specific only to El A of the highly oncogenic Ad 12 serotype by a mechanism whose precise details are not yet clear. However, it appears to involve protein binding to more than one site within a distal sequence (-1.18 to -1.44kb) of the MHC class I 5'-flanking region. It seems probable that cellular factors are involved, either by induction or activation by Adl2 E1A. Ultimately the mechanism adopted by highly oncogenic adenoviruses to reduce the levels of MHC class I antigens results in a highly effective evasion of immune surveillance, permitting the Ad 12-transformed cell to escape from the action of host cytotoxic T lymphocytes and leading to an increase in the efficiency of cellular transformation and oncogenesis.
